36:29
Biomaterials - II.5.16 - Drug Delivery Systems
46:14
Biomaterials - II.4 - Degradation of Biomaterials
37:39
Biocompatibility - Ch. 3 - Leukocyte Circulation and Migration
32:45
Biomaterials - II.6 - Tissue Engineering
37:28
Biocompatibility - Ch. 15 - Immunologic Tolerance and Autoimmunity
41:33
Biocompatibility - Ch. 13 - Effector Mechanisms of Humoral Immunity
38:07
Biocompatibility - Ch. 18 - Immunity to Tumors
40:57
Biocompatibility - Ch. 5 - Antibodies and Antigens
55:03
Biocompatibility - Ch. 2 - Cells and Tissues of the Immune System
40:29
Biocompatibility - Ch. 12 - B Cell Activation
53:40
Biocompatibility - Ch. 4 - Innate Immunity
35:26
Biocompatibility - Ch. 9 Activation of T cells
48:09
Biocompatibility - Ch. 10,11 - CD4+ and CD8+ T cells
58:32
Biocompatibility - Ch. 17 - Transplantation Immunology
33:06
Biomaterials - III.1 - Special Considerations
13:59
Biomaterials - I.3.2 - Polymers
37:17
Biomaterials - I.2 - Property of Materials
40:55
Biomaterials - III.2 - Regulatory Compliance
42:34
Biomaterials - II.3 - Biological Testing of Materials
42:37
Biomaterials - II.2 - Host Reactions to Biomaterials
37:43
Biomaterials - II.1 - Background Concepts
55:52
Biomaterials - I.1 - Material Properties and Metals
38:14
Biomaterials - I.2.2 - Polymers
49:10
Biocompatibility - Ch. 6 - Antigen Presentation to T cells and the MHC
X
About
Tags